Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...
Novo Nordisk (NVO) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback